Drug treatments for covid-19: living systematic review and network meta-analysis
Objective To compare the effects of treatments for coronavirus disease 2019 (covid-19).
Design Living systematic review and network meta-analysis. Data sources WHO covid-19 …
Design Living systematic review and network meta-analysis. Data sources WHO covid-19 …
[HTML][HTML] Antiviral drug treatment for nonsevere COVID-19: a systematic review and network meta-analysis
T Pitre, R Van Alstine, G Chick, G Leung, D Mikhail… - Cmaj, 2022 - Can Med Assoc
Background: Randomized trial evidence suggests that some antiviral drugs are effective in
patients with COVID-19. However, the comparative effectiveness of antiviral drugs in …
patients with COVID-19. However, the comparative effectiveness of antiviral drugs in …
Comparative efficacy and safety of pharmacological interventions for the treatment of COVID-19: A systematic review and network meta-analysis
Background Numerous clinical trials and observational studies have investigated various
pharmacological agents as potential treatment for Coronavirus Disease 2019 (COVID-19) …
pharmacological agents as potential treatment for Coronavirus Disease 2019 (COVID-19) …
Efficacy of COVID-19 treatments: a Bayesian network meta-analysis of randomized controlled trials
Background: We provided a comprehensive evaluation of efficacy of available treatments for
coronavirus disease 2019 (COVID-19). Methods: We searched for candidate COVID-19 …
coronavirus disease 2019 (COVID-19). Methods: We searched for candidate COVID-19 …
Characteristics of registered clinical trials assessing treatments for COVID-19: a cross-sectional analysis
Objectives The coronavirus disease 2019 (COVID-19) pandemic has prompted many
initiatives to identify safe and efficacious treatments, yet little is known regarding where early …
initiatives to identify safe and efficacious treatments, yet little is known regarding where early …
Interventions for treatment of COVID-19: A living systematic review with meta-analyses and trial sequential analyses (The LIVING Project)
S Juul, EE Nielsen, J Feinberg, F Siddiqui… - PLoS …, 2020 - journals.plos.org
Background Coronavirus disease 2019 (COVID-19) is a rapidly spreading disease that has
caused extensive burden to individuals, families, countries, and the world. Effective …
caused extensive burden to individuals, families, countries, and the world. Effective …
Systematic review of the registered clinical trials for coronavirus disease 2019 (COVID-19)
R Zhu, Y Gao, SH Robert, J Gao, S Yang… - Journal of translational …, 2020 - Springer
Background Since the outbreak of coronavirus disease 2019 (COVID-19), many researchers
in China have performed related clinical research. However, systematic reviews of the …
in China have performed related clinical research. However, systematic reviews of the …
Comparative efficacy and safety of nirmatrelvir/ritonavir and molnupiravir for COVID‐19: A systematic review and meta‐analysis
This study aimed to compare the efficacy and safety of nirmatrelvir/ritonavir (Paxlovid) with
molnupiravir in the treatment of coronavirus disease 2019 (COVID‐19). To end this …
molnupiravir in the treatment of coronavirus disease 2019 (COVID‐19). To end this …
Interventions for treatment of COVID-19: of a living systematic review with meta-analyses and trial sequential analyses (The LIVING Project)
S Juul, EE Nielsen, J Feinberg, F Siddiqui… - PLoS …, 2021 - journals.plos.org
Background COVID-19 is a rapidly spreading disease that has caused extensive burden to
individuals, families, countries, and the world. Effective treatments of COVID-19 are urgently …
individuals, families, countries, and the world. Effective treatments of COVID-19 are urgently …
The clinical efficacy and safety of anti-viral agents for non-hospitalized patients with COVID-19: a systematic review and network meta-analysis of randomized …
CC Lai, YH Wang, KH Chen, CH Chen, CY Wang - Viruses, 2022 - mdpi.com
This network meta-analysis compared the clinical efficacy and safety of anti-viral agents for
the prevention of disease progression among non-hospitalized patients with COVID-19 …
the prevention of disease progression among non-hospitalized patients with COVID-19 …
相关搜索
- meta analysis covid 19
- interventions for treatment covid 19
- living project covid 19
- living project interventions for treatment
- drug treatments meta analysis
- meta analysis bayesian network
- nirmatrelvir ritonavir covid 19
- coronavirus disease covid 19
- meta analysis nirmatrelvir ritonavir
- clinical efficacy covid 19
- meta analysis pharmacological interventions
- meta analysis clinical efficacy
- drug treatments covid 19
- pharmacological interventions covid 19